Skip to main content

Site notifications

AusPAR: Alhemo

Australian Public Assessment Report
Device/Product Name
Alhemo
Active ingredients
Concizumab
AusPAR Date
Published
Submission Number
PM-2022-03458-1-6
Submission Type
New biological entity
Decision
Approved

Help us improve the Therapeutic Goods Administration site